| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Credit > How Many Credit Cards Should I Have? |
|
Main Subject - How Many Credit Cards Should I Have?
Enticing credit card offers fill the mailboxes of thousands of Americans every day. Accompanied by amazing offers of zero percent interest for six months and no fees for balance tr According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ansfers, 15% to 20% off your first purchase, discount hotel rates and free movie tickets, the list goes on and on. And on impulse we fall to our knees and sign on the dotted line wi ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in thout thinking about just how much another credit card will affect our families, our credit histories, or our financial futures. Before you sign up for another card, ask yourself w lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. hat is the rule of thumb for credit cards, just how many credit cards is enough? Do you know? Is there a magical number or is it just a matter of how you manage them? If your ans here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe er to all of these questions is I don’t know, read on to find out. Most Americans carry between five to ten credit cards in their wallets, with the average household owing $12,000 d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro in credit card debt. Considering that the median U.S. household income is only $49,772, that is 24% of the income already committed with out considering mortgages or car loans. Thi ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc s is a bit alarming. Especially considering that future creditors prefer to extend credit to individuals or families with a debt to income ratio of 36% or less if 24% of that 36% i easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi s already committed to credit card debt, that doesn’t leave room for much else. So just how many credit cards should you have? Surprisingly there is no magic number; however, two nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically o three credit cards is generally viewed as enough. While there is no magic number, the single most important thing to remember when you encounter the wonderful world of credit car and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ds is that it’s not the number of credit cards that you have, but your outstanding balance and the number of years that an account has been opened. You should aim for an outstandin ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi g balance between 25% to 50% of the available credit on each credit card that you have. Any more than that sends a red flag to potential creditors who see your ability to repay, in ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a the event you are faced with a major financial obstacle, decreasing as your debt increases. Additionally, multiple fairly new accounts are viewed negatively. Something else to co dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod sider is that the fewer number of credit cards you have the easier it is for you to keep track of them. Keeping track of them includes knowing what your interest rates and fees are cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin and any changes that may occur with them or how they are applied. Additionally, with just two to three cards you are in a better position to know exactly where you stand with your tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen balances and your spending. To make sure that your credit is working for you and you aren’t working for it, it is pays to know where you stand; fewer cards help you to stay on top t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel of that. So there is no set number of credit cards that you should or should not have. The key to preventing yourself from getting trapped in the rat race is having a manageable ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust mount, perhaps two or three that you can easily keep track of. It is crucial to know the interest rates for each card, your outstanding balances, and other card features. The next y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products thing is knowing where you stand in terms of your overall debt including credit cards, mortgage, car loans, student loans in comparison to your income. With all of that knowledge . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de in hand, remember two important percentages, the 36% which is ideal for your debt to income ratio and 25 to 50% for your outstanding balances. Data Sources: 1. http://moneycentral elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip .msn.com/content/banking/creditcardsmarts/p123470.asp 2. http://advertising.washpost.com/the_market/top10/income.jsp 3. http://www.wsws.org/articles/2004/jan2004/debt-j15_prn.shtm tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Building Your Prospect List 10 at a Time Invention: The 99% Perspiration Part - Part Two
|